CliniciansreportedinMedthat 5 severely immunocompromised patients critically ill with COVID-19 received interferon gamma therapy as a last resort. All 5 individuals quickly cleared the virus after beginning the off-label treatment, and 4 recovered. The patients had severe defects in their cellular im...
Immunocompromised patients and COVID-19: how do we protect those most at risk?Jochen SchneiderJochen.Schneider@mri.tum.deView further author informationJohanna ErberView further author informationLutz RendersView further author informationChristoph D. Spinner...
ATHENS, Jan. 11 (Xinhua) -- Greece's National Vaccination Committee approved on Tuesday a fourth dose of the COVID-19 vaccines for immunocompromised patients, Greek national news agency AMNA reported. The fourth dose can be administered three months after the third one, it was announced. The ...
COVID-19 is a potentially critical infectious disease. Inflammatory response and disease severity may vary according to immune system status. The aim of this case series is to investigate different presentation of COVID-19 inimmunocompromised patients. ...
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both pr
Patients with cancer have a higher risk of severe coronavirus disease (COVID-19) and associated mortality than the general population. Owing to this increased risk, patients with cancer have been prioritized for COVID-19 vaccination globally, for both pr
2.Goel N, Goyal N, Spalgais S, et al. Initial COVID-19 Severity and Long-COVID Manifestations: An Observational Analysis. Thorac Res Pract 2023;24:22-8. [Crossref] [PubMed] 4.Mozaffari E, Chandak A, Gottlieb RL, et al. Remdesivir reduced mortality in immunocompromised patients hospita...
Immunocompromised patients, including those with inborn errors of immunity, may be at increased risk for severe or prolonged infections with SARS-CoV-2 (Kinoshita et al., 2021). Cancer and organ transplant patients are immunocompromised chiefly due to treatment. Compared to the general population, ...
The Bristol Myers Squibb Foundation launched a food assistance program during COVID-19 for immunocompromised patients.
The COVID-19 pandemic has disproportionately impacted immunocompromised patients. This diverse group is at increased risk for impaired vaccine responses, progression to severe disease, prolonged hospitalizations and deaths. At particular risk are people with deficiencies in lymphocyte number or function such...